TDC
WGS icon

Thompson Davis & Co’s GeneDx Holdings WGS Stock Holding History

Thompson Davis & Co’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$690K Sell
10,050
-5,591
-36% -$318K 0.41% 52
2026
Q1 		$1M Buy
15,641
+750
+5% +$68.4K 0.67% 25
2025
Q4 		$1.94M Hold
14,891
– – 1.16% 9
2025
Q3 		$1.6M Sell
14,891
-2,439
-14% -$266K 0.99% 11
2025
Q2 		$1.6M Buy
17,330
+3,180
+22% +$250K 1.09% 13
2025
Q1 		$1.25M Sell
14,150
-6,980
-33% -$606K 0.99% 12
2024
Q4 		$1.62M Buy
21,130
+6,530
+45% +$456K 1.04% 8
2024
Q3 		$620K Sell
14,600
-7,244
-33% -$245K 0.46% 39
2024
Q2 		$571K Sell
21,844
-2,250
-9% -$42.6K 0.5% 34
2024
Q1 		$220K Buy
24,094
+4,150
+21% +$24.9K 0.15% 83
2023
Q4 		$54.8K Buy
19,944
+9,944
+99% +$23.1K 0.05% 91
2023
Q3 		$36.4K Buy
+10,000
New +$54.8K 0.05% 99
2023
Q2 		– Sell
-4,242
Closed -$51.1K – 136
2023
Q1 		$51.1K Buy
+4,242
New +$56.5K 0.07% 96

Other funds holding WGS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
GC
Grange Capital Beaverton, Oregon $108M AUM 18.7% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Thompson Davis & Co's WGS Position: Q2 2026 in Review

Thompson Davis & Co reduced its GeneDx Holdings (WGS) stake by 36% in Q2 2026, selling an estimated $318K and leaving 10,050 shares worth $690K. The position accounts for 0.41% of the portfolio, ranked #52.

Thompson Davis & Co first reported a position in WGS in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.94M in Q4 2025. 34 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Thompson Davis & Co held 10,050 shares of GeneDx Holdings worth $690K as of Q2 2026.
  • Thompson Davis & Co sold 5,591 GeneDx Holdings shares in Q2 2026, an estimated $318K.
  • GeneDx Holdings made up 0.41% of Thompson Davis & Co's portfolio in Q2 2026, its #52 holding.
  • Thompson Davis & Co first reported a position in GeneDx Holdings in Q1 2023 and has held it in 13 quarters since.
  • Thompson Davis & Co's GeneDx Holdings position peaked at $1.94M in Q4 2025.
  • 34 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Thompson Davis & Co's 13F filing for Q2 2026, filed 29 Jul 2026.